Clinical Trials Logo

Mismatch Repair-deficient (dMMR) clinical trials

View clinical trials related to Mismatch Repair-deficient (dMMR).

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05913570 Not yet recruiting - Colorectal Cancer Clinical Trials

Cadonilimab as Neoadjuvant Therapy in Resectable Stage II-III MSI-H/dMMR Colorectal Cancer

MSI-H/dMMR
Start date: June 20, 2023
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety, and tolerability of Cadonilimab as neoadjuvant treatment for resectable local advanced colorectal cancer patient with dMMR/MSI-H.